[ Price : $8.95]
FDA publishes the International Council for Harmonization M13A guidance on bioequivalence studies for immediate-release solid oral...[ Price : $8.95]
Sage Therapeutics and Biogen decide to not seek an expanded use (major depressive disorder) for postpartum depression drug Zurzuva...[ Price : $8.95]
Rep. Abigail Spanberger asks FDA and DEA for additional information on their efforts to address shortages of ADHD drugs.[ Price : $8.95]
FDA posts the establishment inspection report with seven observations from a 2023 inspection at a Boehringer Ingelheim drug manufa...[ Price : $8.95]
FDA approves the removal of an imaging contraindication on Abbotts FreeStyle Libre 2 and 3 continuous glucose monitoring systems.[ Price : $8.95]
Federal Register notice: FDA makes available additional revised draft product-specific guidances that provide recommendations on b...[ Price : $8.95]
FDA raises questions to be considered at a 10/31 Endocrinologic and Metabolic Drugs Advisory Committee meeting discussing a Lexico...[ Price : $8.95]
FDA and the Veterans Administration say they are partnering to open a virtual laboratory to evaluate health-related artificial int...